Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Shares, par value US$0.001 per share
-
Shares outstanding
-
71,872,133
-
Total 13F shares
-
12,345,841
-
Share change
-
+12,029,230
-
Total reported value
-
$79,877,748
-
Price per share
-
$6.47
-
Number of holders
-
11
-
Value change
-
+$74,637,726
-
Number of buys
-
9
-
Number of sells
-
1
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2024
As of 31 Mar 2024,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,345,841 shares.
The largest 10 holders included
Vivo Capital, LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, JPMORGAN CHASE & CO, UBS Group AG, and GROUP ONE TRADING, L.P..
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.